Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tracy

Showing results (71-80 of 230) with videos related to

Pageof 23
Sort By:
Clinical Orthopaedics and Related Research|May 12, 2001
Hypofibrinolysis, thrombophilia, osteonecrosisC J Glueck, R A Freiberg, R N Fontaine, et al.
The American Journal of Cardiology|May 21, 1999
Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular diseaseC J Glueck, J E Lang, T Tracy, et al.
American Journal of Surgery|December 11, 1991
Congenital diaphragmatic hernia beyond infancyT R Weber, T Tracy, P V Bailey, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimerC J Glueck, H I Glueck, T Tracy, et al.
The Annals of Thoracic Surgery|May 1, 1988
Cricoid split for subglottic stenosis in infancyB A Michna, T M Krummel, T Tracy, et al.
Journal of Pediatric Surgery|January 1, 1990
Mucosal proliferation characteristics in ureterosigmoidostomy: effect of calcium supplementT Weber, R Connors, T Tracy, et al.
American Journal of Industrial Medicine|September 1, 1996
Risk factors for coronary heart disease among firefighters in CincinnatiC J Glueck, W Kelley, P Wang, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1993
Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic menC J Glueck, H I Glueck, D Stroop, et al.
American Journal of Hematology|April 1, 1995
Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with StanozololC J Glueck, R Freiberg, H I Glueck, et al.
Thrombosis and Haemostasis|May 3, 1993
Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?C J Glueck, H I Glueck, L Mieczkowski, et al.
Pageof 23

Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
Clinical Orthopaedics and Related Research|May 12, 2001
Hypofibrinolysis, thrombophilia, osteonecrosisC J Glueck, R A Freiberg, R N Fontaine, et al.
The American Journal of Cardiology|May 21, 1999
Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular diseaseC J Glueck, J E Lang, T Tracy, et al.
American Journal of Surgery|December 11, 1991
Congenital diaphragmatic hernia beyond infancyT R Weber, T Tracy, P V Bailey, et al.
Metabolism: Clinical and Experimental|February 1, 1993
Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimerC J Glueck, H I Glueck, T Tracy, et al.
The Annals of Thoracic Surgery|May 1, 1988
Cricoid split for subglottic stenosis in infancyB A Michna, T M Krummel, T Tracy, et al.
Journal of Pediatric Surgery|January 1, 1990
Mucosal proliferation characteristics in ureterosigmoidostomy: effect of calcium supplementT Weber, R Connors, T Tracy, et al.
American Journal of Industrial Medicine|September 1, 1996
Risk factors for coronary heart disease among firefighters in CincinnatiC J Glueck, W Kelley, P Wang, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1993
Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic menC J Glueck, H I Glueck, D Stroop, et al.
American Journal of Hematology|April 1, 1995
Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with StanozololC J Glueck, R Freiberg, H I Glueck, et al.
Thrombosis and Haemostasis|May 3, 1993
Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?C J Glueck, H I Glueck, L Mieczkowski, et al.
Pageof 23